Inventor
ANDERSON ANNALIESA SYBIL
US52 patents
⚠️ This page may combine multiple inventors who share the name “ANDERSON ANNALIESA SYBIL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
30 patentsUS9724402B2Aug 8, 2017
Neisseria meningitidis composition and methods thereof
PFIZER22 citations94
US10226525B2Mar 12, 2019
Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
PFIZER18 citations93
US10196429B2Feb 5, 2019
Neisseria meningitidis composition and methods thereof
PFIZER12 citations92
US9561269B2Feb 7, 2017
Neisseria meningitidis compositions and methods thereof
PFIZER19 citations92
US8986710B2Mar 24, 2015
Neisseria meningitidis compositions and methods thereof
PFIZER26 citations92
US9802987B2Oct 31, 2017
Immunogenic fusion polypeptides
PFIZER17 citations91
US9822150B2Nov 21, 2017
Neisseria meningitidis compositions and methods thereof
PFIZER17 citations90
US10550159B2Feb 4, 2020
Neisseria meningitidis composition and methods thereof
PFIZER11 citations86
US10829521B2Nov 10, 2020
Neisseria meningitidis composition and methods thereof
PFIZER5 citations84
US10543267B2Jan 28, 2020
Neisseria meningitidis compositions and methods thereof
PFIZER11 citations84
US10982198B2Apr 20, 2021
Compositions and methods relating to a mutant Clostridium difficile toxin
PFIZER4 citations83
US10946086B2Mar 16, 2021
Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
PFIZER5 citations83
US10787652B2Sep 29, 2020
Compositions and methods relating to a mutant clostridium difficile toxin
PFIZER6 citations83
US10899802B2Jan 26, 2021
Neisseria meningitidis compositions and methods thereof
PFIZER4 citations82
US10751402B2Aug 25, 2020
Immunogenic compositions and uses thereof
PFIZER5 citations82
US10183070B2Jan 22, 2019
Neisseria meningitidis compositions and methods thereof
PFIZER12 citations82
US11208633B2Dec 28, 2021
Compositions and methods relating to a mutant Clostridium difficile toxin
PFIZER3 citations72
US12016913B2Jun 25, 2024
Immunogenic compositions and uses thereof
PFIZER1 citations71
US11730800B2Aug 22, 2023
Neisseria meningitidis compositions and methods thereof
PFIZER2 citations71
US11147865B2Oct 19, 2021
Immunogenic compositions and uses thereof
PFIZER3 citations71
US10888611B2Jan 12, 2021
Neisseria meningitidis compositions and methods thereof
PFIZER6 citations71
US10813989B2Oct 27, 2020
Neisseria meningitidis compositions and methods thereof
PFIZER3 citations71
US11260119B2Mar 1, 2022
Escherichia coli compositions and methods thereof
PFIZER3 citations70
US11952597B2Apr 9, 2024
Compositions and methods relating to a mutant Clostridium difficile toxin
PFIZER0 citations62
US11472850B2Oct 18, 2022
Neisseria meningitidis composition and methods thereof
PFIZER0 citations62
US12527855B2Jan 20, 2026
Immunogenic compositions and uses thereof
PFIZER0 citations61
US11680087B2Jun 20, 2023
Neisseria meningitidis compositions and methods thereof
PFIZER0 citations61
US12383611B2Aug 12, 2025
Neisseria meningitidis compositions and methods thereof
PFIZER1 citations59
US12128095B2Oct 29, 2024
Escherichia coli compositions and methods thereof
PFIZER0 citations59
US12569547B2Mar 10, 2026
Immunogenic compositions against Clostridioides (Clostridium) difficile and methods thereof
PFIZER0 citations49
WYETH LLC
15 patentsUS8557548B2Oct 15, 2013
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC25 citations96
US10597428B2Mar 24, 2020
Compositions relating to a mutant clostridium difficile toxin and methods thereof
WYETH LLC7 citations92
US9745354B2Aug 29, 2017
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC15 citations92
USRE46518EAug 22, 2017
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC9 citations92
USRE46376EApr 25, 2017
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC9 citations92
US9187536B1Nov 17, 2015
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC19 citations92
US8900597B2Dec 2, 2014
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC15 citations92
US11535652B2Dec 27, 2022
Compositions relating to a mutant clostridium difficile toxin and methods thereof
WYETH LLC2 citations84
USRE48863EDec 28, 2021
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC3 citations84
USRE48862EDec 28, 2021
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC3 citations84
US11077180B2Aug 3, 2021
Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
WYETH LLC8 citations84
US10774117B2Sep 15, 2020
Compositions relating to a mutant clostridium difficile toxin and methods thereof
WYETH LLC6 citations84
US10512681B2Dec 24, 2019
Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
WYETH LLC12 citations84
US7914798B2Mar 29, 2011
Compositions and methods of use of ORF1358 from beta-hemolytic streptococcal strains
WYETH LLC0 citations45
US7754226B2Jul 13, 2010
Compositions and methods of use of ORF 554 from beta hemolytic streptococcal strains
WYETH LLC0 citations45
SIDHU MANINDER K
1 patentANDERSON ANNALIESA SYBIL
1 patentDODGE INGRID LEA
1 patentVALNEVA AUSTRIA GMBH
1 patentUNIV MINNESOTA
1 patentShowing the top 50 of 52 patents by PatentIndex Score.